Latest Sofinnova Ventures Stories
SVP IX fund to invest primarily in late-stage biopharmaceutical companies MENLO PARK, Calif., July 23, 2014 /PRNewswire/ -- Sofinnova Ventures, a Menlo Park based investment firm, today announced the closing of Sofinnova Venture Partners IX, L.P. at the hard cap of $500 million and in excess of the initial fund target of $425 million. http://photos.prnewswire.com/prnvar/20130724/SF52046LOGO-b Sofinnova focuses exclusively on helping entrepreneurs build successful biotechnology...
BURLINGAME, Calif., Feb. 10, 2014 /PRNewswire/ -- First Aid Shot Therapy® (F.A.S.T.), a consumer healthcare company focused on over-the-counter (OTC) medicine in liquid 'shot' (40ml / 1.35oz.) form, announced today that it has completed a Series B financing round. Sofinnova Ventures and Redmile Group co-led the round with additional support from investors including Sofinnova HealthQuest, Clearwell Group and Mark Rampolla, Founder and former CEO of ZICO Beverages, maker of ZICO Pure...
BRISBANE, Calif., July 18, 2011 /PRNewswire/ -- SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners. (Logo: http://photos.prnewswire.com/prnh/20110718/FL36481LOGO ) "We believe that SARcode is uniquely positioned...
- A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
- A gentle breeze; a waft; a breath.
- Any rumor that engages general attention.
- To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
- To breathe in or as in sleep.
- To utter in a whining or monotonous tone.